title: Computational prediction of human drug metabolism.
abstract: There is an urgent requirement within the pharmaceutical and biotechnology industries, regulatory authorities and academia to improve the success of molecules that are selected for clinical trials. Although absorption, distribution, metabolism, excretion and toxicity (ADME/Tox) properties are some of the many components that contribute to successful drug discovery and development, they represent factors for which we currently have in vitro and in vivo data that can be modelled computationally. Understanding the possible toxicity and the metabolic fate of xenobiotics in the human body is particularly important in early drug discovery. There is, therefore, a need for computational methodologies for uncovering the relationships between the structure and the biological activity of novel molecules. The convergence of numerous technologies, including high-throughput techniques, databases, ADME/Tox modelling and systems biology modelling, is leading to the foundation of systems-ADME/Tox. Results from experiments can be integrated with predictions to globally simulate and understand the likely complete effects of a molecule in humans. The development and early application of major components of MetaDrug (GeneGo, Inc.) software will be described, which includes rule-based metabolite prediction, quantitative structure-activity relationship models for major drug metabolising enzymes, and an extensive database of human protein-xenobiotic interactions. This represents a combined approach to predicting drug metabolism. MetaDrug can be readily used for visualising Phase I and II metabolic pathways, as well as interpreting high-throughput data derived from microarrays as networks of interacting objects. This will ultimately aid in hypothesis generation and the early triaging of molecules likely to have undesirable predicted properties or measured effects on key proteins and cellular functions.
authors.affiliation: GeneGo, Inc., 500 Renaissance Drive, Suite 106, St. Joseph, MI 49085, USA. sean@genego.com
authors.forename: Sean
authors.initials: S
authors.lastname: Ekins
authors.forename: Sergey
authors.initials: S
authors.lastname: Andreyev
authors.forename: Andy
authors.initials: A
authors.lastname: Ryabov
authors.forename: Eugene
authors.initials: E
authors.lastname: Kirillov
authors.forename: Eugene A
authors.initials: EA
authors.lastname: Rakhmatulin
authors.forename: Andrej
authors.initials: A
authors.lastname: Bugrim
authors.forename: Tatiana
authors.initials: T
authors.lastname: Nikolskaya
mesh_terms: D019295:Computational Biology / Q000379:methods* / Q000639:trends; D004347:Drug Interactions; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D004364:Pharmaceutical Preparations / Q000008:administration & dosage / Q000378:metabolism*; D012984:Software; D013678:Technology, Pharmaceutical / Q000379:methods* / Q000639:trends
chemical_list: D004364:Pharmaceutical Preparations